Efficacy and Safety of Rituximab in Relapsing and Progressive Multiple Sclerosis: a Hospital-Based Study
Journal of Neurology（2018）
Key words
Multiple sclerosis,Relapsing-remitting multiple sclerosis,Progressive multiple sclerosis,Treatment,Rituximab,Anti-CD20 monoclonal antibody
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined